Method for preventing or reducing risk of onset of cardiovascular events employing an HMG CoA reductase inhibitor

摘要

A method is provided for preventing or reducing the risk of onset of a cardiovascular event by administering an HMG CoA reductase inhibitor such as pravastatin, to a patient which has one or more risk factors for a coronary and/or cerebrovascular event such as hypercholesterolemia.